Skip to Content

LU K71 (Quetiapine Fumarate Extended-Release 50 mg)

Pill with imprint LU K71 is Red, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 50 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU K71

Quetiapine Fumarate Extended-Release

Imprint
LU K71
Strength
50 mg
Color
Red
Size
11.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
68180-0612
Inactive Ingredients
microcrystalline cellulose, ferric oxide red, ferric oxide yellow, hypromellose 2208 (15000 mPa.s), hypromellose 2910 (6 mPa.s), hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol 400, titanium dioxide, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.